logo
Red Coin, Blue Coin: The New Politics of Exposure

Red Coin, Blue Coin: The New Politics of Exposure

Yahooa day ago
It was only a matter of time. With Strategy long reigning as the go-to corporate proxy for bitcoin exposure, it was inevitable that a challenger would emerge — though few expected it to wear a red hat and run a social media company. Trump Media & Technology Group's recent announcement that it holds roughly $2 billion in bitcoin has transformed it, overnight, into a serious — if unconventional — bitcoin-treasury company.
But for investors seeking crypto exposure, the question isn't just about how much bitcoin a company holds. It's about what else comes with the package.
In one corner, we have Strategy (formerly MicroStrategy): the bitcoin standard-bearer, helmed by Michael Saylor, who has spent the past four years turning a sleepy enterprise software company into a de facto digital gold vault. Saylor has become bitcoin's most prominent corporate evangelist, turning Strategy into a digital gold vault with quarterly earnings calls that double as bitcoin sermons.
In the other corner, enter Trump Media (DJT), which operates the Truth Social platform and has a revenue stream you could mistake for a rounding error: $4.1 million in 2023, compared to Strategy's $498 million. Yet its market cap has floated above $6 billion — a valuation propped up almost entirely by brand loyalty, media spectacle, and now, bitcoin.
Let's be clear: DJT didn't just buy some bitcoin. It bought a lot of it — enough to vault it into the upper echelon of corporate BTC holders. On paper, that makes it interesting. But this isn't your typical balance-sheet play. This is bitcoin by way of meme stock, populist vehicle, and culture war capital. And for investors looking for crypto exposure, it raises an uncomfortable — and increasingly unavoidable — question: What happens when your bitcoin proxy stock comes with a political identity?
Strategy's bitcoin play, while bold, has always been pitched as a rational (some might say religious) hedge against inflation and fiat debasement. Its founder doesn't dabble in politics (outside of poking fun at altcoins), and the company isn't staging rallies or trending on Truth Social. It's all-in on bitcoin — not ideology.
Trump Media, by contrast, is ideology-first. Its brand, valuation, and customer base are inseparable from Donald Trump's political identity. With bitcoin now making up the overwhelming majority of the company's assets, this is less a treasury decision than a wholesale pivot. But in practice, it functions more like a cultural signal — a declaration of alignment with the anti-establishment, pro-sovereignty values that animate its most loyal followers.
That's not a bad strategy, necessarily. It might even be a brilliant one. The marriage of Trumpism and bitcoin isn't as odd as it sounds. Both reject centralized authority. Both thrive on defiance. Both are, depending on your viewpoint, revolutionary or rebellious — and always controversial.
But for investors who simply want crypto exposure in their portfolio, the emergence of politically branded bitcoin stocks presents a new kind of risk. What happens when bitcoin becomes tribal? What happens when each side of the political aisle has its own bitcoin company, its own bitcoin ETF, its own financial media ecosystem?
In this new paradigm, bitcoin exposure could become not just a financial choice, but a cultural affiliation. Imagine a left-leaning climate-tech firm launching 'Green Bitcoin Holdings, Inc.' to push eco-friendly mining. Or a libertarian group creating 'Freedom Ledger Corp.' to promote bitcoin as a tool for tax resistance and personal sovereignty. Bitcoin could become the financial equivalent of cable news: red coins, blue coins, and perpetual outrage.
That's a far cry from bitcoin's original promise as a neutral, decentralized alternative to fiat. It was supposed to be trustless. Borderless. Immune to capture. But when its biggest corporate champions start behaving like political action committees it threatens to drag bitcoin into the very systems it was designed to transcend.
So where does that leave investors?
If you're looking for a relatively clean bitcoin proxy, Strategy still offers the clearest path. Its volatility is real — but it's the volatility of conviction. Trump Media, on the other hand, is a bet on narrative, loyalty, and virality. It might outperform in the short term. It might even spark a whole new class of politically-infused crypto equities. But it's no longer just about bitcoin. It's about who owns the story around bitcoin.
The final irony? Bitcoin itself doesn't care. It doesn't care who your CEO is. It doesn't care who your president is. It just keeps producing blocks, one every ten minutes, indifferent to spin, slogans, or Senate hearings (until 21 million is reached – at which point the political tribe with the biggest BTC treasury wins?).
But investors do care. And as bitcoin enters this new phase of cultural colonization, we'd all be wise to ask: Are we buying the coin — or the campaign?
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Option Care Health, Inc. (OPCH): A Bull Case Theory
Option Care Health, Inc. (OPCH): A Bull Case Theory

Yahoo

time5 minutes ago

  • Yahoo

Option Care Health, Inc. (OPCH): A Bull Case Theory

We came across a bullish thesis on Option Care Health, Inc. on Brian's Substack by Brian Flasker. In this article, we will summarize the bulls' thesis on OPCH. Option Care Health, Inc.'s share was trading at $29.35 as of July 31st. OPCH's trailing and forward P/E were 23.29 and 19.65, respectively according to Yahoo Finance. A home infusion nurse in full PPE gown delivering treatments to a patient in their own home. Option Care Health (OPCH) has evolved into the dominant independent provider of home and alternate site infusion services in the U.S., originating from Madison Dearborn Partners' 2015 acquisition of Walgreens Infusion Services. The 2019 reverse merger with BioScrip and full divestiture by Walgreens and MDP by 2023 paved the way for OPCH to operate with full independence. Led by CEO John Rademacher and CFO Michael Shapiro, both with substantial equity stakes, OPCH has built a national infrastructure of 91 pharmacies and 99 infusion suites, covering 96% of the U.S. population. The company's integrated model provides cost-effective, high-quality infusion therapies in outpatient and home settings, capitalizing on a healthcare trend shifting treatments away from costly hospitals. This platform serves over 1,400 contracts with 800+ partners, including all top 10 national insurers. Acute therapies, though operationally complex, act as a competitive wedge, while chronic therapies anchor long-term recurring revenues. OPCH's mix—75% chronic, 25% acute—combined with a focus on generics and biosimilars, ensures resilience against pricing volatility. With its Advanced Practitioner (AP) model, OPCH is pushing clinical boundaries, managing more complex therapies in lower-cost settings and enhancing utilization of its already-built infrastructure. Only ~50% of its infusion suite capacity is currently utilized, leaving ample runway for capital-light growth. Despite industry concerns like drug pricing reforms and labor shortages, OPCH's embedded relationships, clinical capabilities, and scalable model offer strong visibility into cash flow and earnings. Trading at ~15.4x 2025 owner earnings with a 17.4% expected IRR, OPCH represents a high-quality compounder with an entrenched moat and significant upside. Previously, we covered a bullish thesis on Chemed Corporation by 310 Value in April 2025, which highlighted the durability of its earnings, temporary volatility in its subsidiaries, and disciplined share repurchases. The company's stock price has depreciated by approximately 29% since our coverage. This is because temporary segment headwinds persisted longer than expected. The thesis still stands as Chemed's core fundamentals remain intact. Brian Flasker shares a similar view but emphasizes OPCH's capital-light model and payer-aligned infrastructure. Option Care Health, Inc. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 40 hedge fund portfolios held OPCH at the end of the first quarter, which was 40 in the previous quarter. While we acknowledge the potential of OPCH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Steel Dynamics, Inc. (STLD): A Bull Case Theory
Steel Dynamics, Inc. (STLD): A Bull Case Theory

Yahoo

time5 minutes ago

  • Yahoo

Steel Dynamics, Inc. (STLD): A Bull Case Theory

We came across a bullish thesis on Steel Dynamics, Inc. on Stock Picker's Journey's Substack by Gregg Jahnke. In this article, we will summarize the bulls' thesis on STLD. Steel Dynamics, Inc. 's share was trading at $127.56 as of July 31st. STLD's trailing and forward P/E were 18.51 and 14.29 respectively according to Yahoo Finance. Steel Dynamics (STLD) has been added to the Model 25 portfolio at $131, replacing AES, in a rare top-down decision driven by macroeconomic expectations rather than valuation. While the author typically favors bottom-up stock picks like Pepsi and Gentex, which were purchased at near-decade lows, the potential passage of the BBBill and a possible economic surge in 2026 prompted this more thematic move. STLD stands to benefit from pro-growth industrial policies, and with momentum shifting in favor of the bill's passage, exposure to a high-quality cyclical stock became desirable. A standout first-quarter earnings call reinforced conviction, as STLD's aggressive capital expenditure plans—particularly its efforts to reshape the aluminum industry—signal long-term vision. Notably, the company has repurchased 40% of its stock over the past decade and maintains a clean balance sheet, having recently refinanced debt with manageable near-term maturities. Although other aluminum plays like Century, Alcoa, and Kaiser were considered, STLD was viewed as superior, even compared to Nucor (NUE), due to its aluminum exposure. Wall Street's focus on short-term earnings has led to a misunderstanding of STLD's strategic positioning, as highlighted by analyst John Tumazos's incisive questioning on the Q1 call. The company's spread-based model in scrap steel and aluminum is seen as lower risk than perceived, with significant upside potential. Strong institutional support from Victory Capital, Norges Bank, and T. Rowe Price adds credibility to the investment. Though STLD has underperformed recently and issued a soft Q2 outlook, the long-term case for its role in rebuilding U.S. manufacturing justifies the timing of this buy. Previously, we covered a on Steel Dynamics, Inc. (STLD) by Gregg Jahnke in February 2025, which highlighted the company's capital discipline, low-cost structure, and long-term potential. The company's stock price has depreciated approximately by 4% since our coverage due to near-term macro headwinds. Gregg Jahnke shares a similar view but emphasizes a top-down, policy-driven case based on expected 2026 growth. Steel Dynamics, Inc. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 45 hedge fund portfolios held STLD at the end of the first quarter which was 45 in the previous quarter. While we acknowledge the potential of STLD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Snap-on Incorporated (SNA): A Bull Case Theory
Snap-on Incorporated (SNA): A Bull Case Theory

Yahoo

time5 minutes ago

  • Yahoo

Snap-on Incorporated (SNA): A Bull Case Theory

We came across a bullish thesis on Snap-on Incorporated on The Reservist's Substack by Yehoshua Zlotogorski. In this article, we will summarize the bulls' thesis on SNA. Snap-on Incorporated's share was trading at $321.19 as of July 31st. SNA's trailing and forward P/E were 17.11 and 17.24, respectively according to Yahoo Finance. An engineer at a workbench surrounded by automotive parts, tools, and microchips. Snap-On's latest earnings report reinforces the author's conviction in a trade built on a favorable risk/reward setup. The position, entered with a tight downside near $300 (a 3% loss), is based on Snap-On's strong fundamentals and dominant market position, which help anchor valuation. The key bullish thesis is that the post-pandemic lull in tool and equipment purchases—now entering its final stages- will fade by late 2025 into 2026, setting up for a cyclical rebound. This quarter supports that view: the Tools Group returned to growth (+1.7%) after four quarters of decline, RS&I also expanded, and while C&I fell 8%, the drop was attributed largely to temporary effects, with a recovery seen as the quarter progressed. Management continues to deflect with macro and geopolitical explanations, but the author sees the stagnation as a result of pandemic-era pull-forward, supported by weak financing data for big-ticket items. As these loans roll off over their typical four-year cycles, demand should return. The author also sees Snap-On as a likely beneficiary of tariff relief and potential industrial spending from the so-called 'Big Beautiful bill,' both of which could drive relative outperformance. Meanwhile, margins remain strong, cash builds, buybacks persist, and the 2.75% dividend provides a steady return while awaiting the upturn. The stock could rise 30% back to its historical $370–390 range, with minimal downside. Sized at 4% of the portfolio, the position provides lower beta industrial exposure while retaining the upside target common across the author's broader trading strategy. Further adds are possible on dips near $300. Previously, we covered a on Snap-on Incorporated (SNA) by William Fleming-Daniels in November 2024, which highlighted strong margins, stable cash flow, and long-term growth. The company's stock has depreciated ~11% since our coverage, as the thesis hasn't played out yet. Yehoshua Zlotogorski shares a similar view but emphasizes a near-term cyclical rebound driven by financing roll-offs. Snap-on Incorporated is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 36 hedge fund portfolios held SNA at the end of the first quarter which was 32 in the previous quarter. While we acknowledge the potential of SNA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store